Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
134.89
-2.17 (-1.58%)
Official Closing Price
Updated: 6:30 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
57
58
Next >
Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments
January 10, 2024
Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.
Via
Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
January 10, 2024
Via
Benzinga
Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy
January 10, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk A/S (NYSE: NVO), shared insights during the JPMorgan Healthcare conference, highlighting Wegovy's efficacy for weight loss, indicating that patients are...
Via
Benzinga
3 Simple Tricks That Every Investor Should Use (but Most Don't)
January 09, 2024
Having a few tricks up your sleeve can increase your returns over time.
Via
The Motley Fool
Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles
January 09, 2024
Monday, at the JP Morgan Healthcare Conference, Pfizer Inc (NYSE: PFE) CEO Albert Bourla expressed that the company is determined to move forward in the burgeoning
Via
Benzinga
Could Novo Nordisk Stock Help You Retire a Millionaire?
January 08, 2024
This company is steadily gaining in value, and its growth runway is quite long, too.
Via
The Motley Fool
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
January 05, 2024
Via
Benzinga
Can Simply Good Foods ride the GLP-1 weight loss trend in 2024?
January 09, 2024
Simply Good Foods may be ready to breakout as the GLP-1 medication weight-loss trend is driving up sales for its Atkins and Quest Nutrition branded products
Via
MarketBeat
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
January 08, 2024
Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other...
Via
Benzinga
Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales
January 08, 2024
Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.
Via
Investor's Business Daily
Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate
January 08, 2024
Novo Nordisk A/S (NYSE: NVO) announced topli
Via
Benzinga
Voyager Therapeutics stock pops 30% on deal with Novartis
January 08, 2024
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took
Via
MarketBeat
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
Via
Investor Brand Network
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:PFE),(NYSE:MRK),(NASDAQ:AZN),(NYSE:NVO) EQNX::TICKER_END
Via
FinancialNewsMedia
2 low-priced gene therapy stocks to speculate on
January 08, 2024
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe
Via
MarketBeat
Exposures
Product Safety
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Via
MarketBeat
Topics
ETFs
Nvidia, Spotify Lead Five Stocks Near Buy Points
January 06, 2024
Nvidia could make some noise with its CES presentation Monday.
Via
Investor's Business Daily
Why Is WeightWatchers (WW) Stock Down 5% Today?
January 05, 2024
Investors in Weight Watchers and WW stock are seeing more declines today, as investors price in the impact of a rival's new site.
Via
InvestorPlace
Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
January 05, 2024
Tesla, Apple and Mobileye were key losers.
Via
Investor's Business Daily
Novo Nordisk's Ozempic And Wegovy Helps Lose Weight, Not One's Mind: US Study Find No Increased Suicidal Thoughts Risk
January 05, 2024
On Friday, a comprehensive U.S.
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 05, 2024
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
Global Giants: 3 Multinational Corporations to Outperform in 2024
January 04, 2024
Participate in the growth of the global economy and consumption through these leading global stocks for 2024.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Why Novo Nordisk Stock Crushed the Market Today
January 04, 2024
The company just boosted its research and development efforts.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
Via
Benzinga
Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines
January 04, 2024
Eli Lilly announced a new website allowing patients to get a weight loss drug prescription through a telehealth provider, with disease management resources, home delivery of medicines.
Via
Benzinga
Eli Lilly Beefs Up Its Weight-Loss Marketing Efforts With New Direct-To-Consumer Site
January 04, 2024
Eli Lilly will connect patients with doctors, support and direct-to-home delivery of specific medicines.
Via
Investor's Business Daily
Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
January 04, 2024
Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.
Via
Benzinga
Is the January Effect reliable indicator for yearly performance?
January 04, 2024
The January Effect refers to January’s market return as predictive of the full year. But is January's performance truly an indicator of how the year may go?
Via
MarketBeat
Topics
ETFs
Novo Nordisk, The Weight-Loss Kingpin, Inks Two New Obesity Deals
January 04, 2024
Shares of one new partner nearly doubled after Novo Nordisk pledged to pay up to $532 million.
Via
Investor's Business Daily
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
57
58
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.